Literature DB >> 33170442

Effect of Erythropoietin on Calcification of Vascular Smooth Muscle Cells and Its Molecular Regulatory Mechanism.

Xunjia Li1, Xushun Jiang1, Fang He1, Yunfeng Xia1, Xuemei Chen2, Xiaogang Du1,3, Hua Gan4.   

Abstract

To investigate its effect and molecular regulatory mechanism on vascular calcification, EPO was added to vascular smooth muscle cells cultured in vitro and injected intraperitoneally into SD rats. The effect of EPO on VSMC calcification was determined by alizarin red staining and ALP activity. Differentially expressed genes were screened by transcriptome sequencing and the relationship and function were verified. We found EPO promotes VSMC calcification in vitro and blood calcification in vivo in a dose-dependent manner. A total of 88 upregulated genes and 59 downregulated genes were detected in transcriptome sequencing, among which the expression of genes associated with bone formation exhibited a marked increase, namely the GATA6 transcription factor, BMP2, RUNX2, OPN, and OCN. Dual luciferase assay has indicated that the binding of GATA6 to BMP2 promoter facilitates the transcription of BMP2. Taken together, findings indicate that EPO can enhance the calcification of VSMCs by activating the GATA6/BMP2 signal axis.

Entities:  

Keywords:  BMP2; Calcification; EPO; GATA6; VSMCs

Mesh:

Substances:

Year:  2020        PMID: 33170442     DOI: 10.1007/s12265-020-10081-w

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  29 in total

1.  Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.

Authors:  Jula K Inrig; Huiman X Barnhart; Donal Reddan; Uptal D Patel; Shelly Sapp; Robert M Califf; Ajay K Singh; Lynda A Szczech
Journal:  Am J Kidney Dis       Date:  2012-04-25       Impact factor: 8.860

2.  High-phosphate induced vascular calcification is reduced by iron citrate through inhibition of extracellular matrix osteo-chondrogenic shift in VSMCs.

Authors:  Paola Ciceri; Monica Falleni; Delfina Tosi; Carla Martinelli; Gaetano Bulfamante; Geoofrey A Block; Piergiorgio Messa; Mario Cozzolino
Journal:  Int J Cardiol       Date:  2019-10-08       Impact factor: 4.164

3.  WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression.

Authors:  Ting Cai; Danqin Sun; Ying Duan; Ping Wen; Chunsun Dai; Junwei Yang; Weichun He
Journal:  Exp Cell Res       Date:  2016-06-16       Impact factor: 3.905

4.  Lactate accelerates calcification in VSMCs through suppression of BNIP3-mediated mitophagy.

Authors:  Yi Zhu; Jing-Jing Ji; Rui Yang; Xi-Qiong Han; Xue-Jiao Sun; Wen-Qi Ma; Nai-Feng Liu
Journal:  Cell Signal       Date:  2019-03-06       Impact factor: 4.315

5.  Epoetin requirements predict mortality in hemodialysis patients.

Authors:  Yi Zhang; Mae Thamer; Kevin Stefanik; James Kaufman; Dennis J Cotter
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

6.  Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.

Authors:  Lynda A Szczech; Huiman X Barnhart; Jula K Inrig; Donal N Reddan; Shelly Sapp; Robert M Califf; Uptal D Patel; Ajay K Singh
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

7.  Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway.

Authors:  Jun-Kun Zhan; Pan Tan; Yan-Jiao Wang; Yi Wang; Jie-Yu He; Zhi-Yong Tang; Wu Huang; You-Shuo Liu
Journal:  Cardiovasc Diabetol       Date:  2014-11-19       Impact factor: 9.951

8.  Advanced glycation end products accelerate calcification in VSMCs through HIF-1α/PDK4 activation and suppress glucose metabolism.

Authors:  Yi Zhu; Wen-Qi Ma; Xi-Qiong Han; Ying Wang; Xin Wang; Nai-Feng Liu
Journal:  Sci Rep       Date:  2018-09-13       Impact factor: 4.379

9.  Prevalence and Risk Factors of Chronic Kidney Disease among Type 2 Diabetes Patients: A Cross-Sectional Study in Primary Care Practice.

Authors:  Janjira Jitraknatee; Chidchanok Ruengorn; Surapon Nochaiwong
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

10.  Correction of Anemia in Chronic Kidney Disease With Angelica sinensis Polysaccharide via Restoring EPO Production and Improving Iron Availability.

Authors:  Kaiping Wang; Jun Wu; Jingya Xu; Saisai Gu; Qiang Li; Peng Cao; Mingming Li; Yu Zhang; Fang Zeng
Journal:  Front Pharmacol       Date:  2018-07-31       Impact factor: 5.810

View more
  3 in total

1.  Inflammation promotes erythropoietin induced vascular calcification by activating p38 pathway.

Authors:  Xunjia Li; Chengxuan Liu; Ying Li; Weijian Xiong; Deyu Zuo
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

2.  lncRNA TUG1 Facilitates Colorectal Cancer Stem Cell Characteristics and Chemoresistance by Enhancing GATA6 Protein Stability.

Authors:  Junfeng Sun; Hangyuan Zhou; Xingqi Bao; Yue Wu; Haowei Jia; Hongchao Zhao; Guanghui Liu
Journal:  Stem Cells Int       Date:  2021-11-23       Impact factor: 5.443

Review 3.  Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches.

Authors:  Begoña López; Susana Ravassa; María U Moreno; Gorka San José; Javier Beaumont; Arantxa González; Javier Díez
Journal:  Nat Rev Cardiol       Date:  2021-02-10       Impact factor: 32.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.